{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04741646",
            "orgStudyIdInfo": {
                "id": "1U01DK122013-01",
                "type": "NIH",
                "link": "https://reporter.nih.gov/quickSearch/1U01DK122013-01"
            },
            "secondaryIdInfos": [
                {
                    "id": "1U01DK122013",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/1U01DK122013"
                },
                {
                    "id": "22-001133",
                    "type": "OTHER",
                    "domain": "UCLA IRB"
                }
            ],
            "organization": {
                "fullName": "University of California, Los Angeles",
                "class": "OTHER"
            },
            "briefTitle": "Ferric Citrate and Chronic Kidney Disease in Children",
            "officialTitle": "Phosphate Binder Therapy and Chronic Kidney Disease in Children",
            "acronym": "FIT4KID",
            "therapeuticArea": [
                "Nephrology and Renal Diseases"
            ],
            "study": "ferric-citrate-and-chronic-kidney-disease-in-children"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-05-16",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-02-02",
            "studyFirstSubmitQcDate": "2021-02-02",
            "studyFirstPostDateStruct": {
                "date": "2021-02-05",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-10",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-14",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Isidro Salusky, MD",
                "investigatorTitle": "Distinguished Professor of Pediatrics at the David Geffen School of Medicine at UCLA, Chief of Pediatric Nephrology and Director of the Pediatric Dialysis Program",
                "investigatorAffiliation": "University of California, Los Angeles"
            },
            "leadSponsor": {
                "name": "University of California, Los Angeles",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "We will conduct a 12-month, double-blind, randomized, placebo-controlled trial to assess the effects of therapy with ferric citrate (FC) on changes in intact FGF23 levels (iFGF23, primary endpoint) in 160 pediatric patients (80 in each of the two arms) aged 6-18 years of either sex with chronic kidney disease (CKD) stages 3-4 and age-appropriate normal serum phosphate levels. Participants will be randomized to one of the two groups: 1) FC or 2) FC placebo. Participants will be recruited from 12 core clinical sites.",
            "detailedDescription": "We will conduct a double-blind, randomized, placebo-controlled trial to assess the effects of therapy with ferric citrate (FC) on changes in intact FGF23 levels (iFGF23, primary endpoint) aged 6-18 years of either sex with chronic kidney disease (CKD) stages 3-4 and age-appropriate normal serum phosphate levels. Participants will be randomized to one of the two groups: 1) FC or 2) FC placebo. Participants will be recruited from 12 core clinical sites.\n\nSchedule of Intervention: During the 12-month trial, participants will be given a daily fixed weight-based dose of FC.\n\nSchedule for data collection/analyses to be performed:\n\nBlood for primary outcome assessments will be collected at screening, baseline and at months 3, 6, 9, 12. Blood for safety assessments will be collected at the same intervals.\n\nThe primary analyses for this 2-arm trial will evaluate changes from baseline in iFGF23 levels over 12 months between the treatment and the placebo arms. The analysis will use a linear mixed-effects model, with random participant effects accounting for repeated measurements, random site effects accounting for clustering of participants into study sites, and a fixed treatment effect, which interacts with a time indicator (Months 3-12 vs. Months 1-3).\n\nPrimary objectives:\n\n* To assess the effects of therapy with FC on changes in iFGF23 levels\n* To determine safety and tolerability of FC.\n\nSecondary objectives:\n\n\u2022 To assess the effects of FC on anemia and indices of mineral and bone metabolism.\n\nPrimary Endpoint:\n\n\u2022 Change in iFGF23 level\n\nSafety and Tolerability Endpoints:\n\n\u2022 Ability to safely tolerate FC\n\nSecondary Endpoints:\n\n* Change in anemia\n* Change in the indices of mineral and bone metabolism\n\nThis is a Phase 2 study with participation from 12 sites that will take 36 months to complete enrollment and a total of 48 months to complete data collection with each participant being part of the study for 12 months.\n\nStudy website: fit4kid.dgsom.ucla.edu"
        },
        "conditionsModule": {
            "conditions": [
                "Chronic Kidney Diseases"
            ],
            "keywords": [
                "Pediatric",
                "CKD",
                "Phosphate Binder"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 160,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Treatment Arm",
                    "type": "EXPERIMENTAL",
                    "description": "During the 12-month trial, participants will be given a fixed weight-based dose of Ferric Citrate (FC). The full medication dose will be 3g/day for participants weighing \\<31 kg, 5g/day for those weighing \\>31 - \\<51 kg, and 6g/day for participants \\>51 kg. These doses will be divided into three doses to be taken with meals.",
                    "interventionNames": [
                        "Drug: Ferric Citrate"
                    ]
                },
                {
                    "label": "Control Arm",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "During the 12-month trial, participants will be given a fixed weight-based dose of Placebo. The full medication dose will be 3g/day for participants weighing \\<31 kg, 5g/day for those weighing \\>31 - \\<51 kg, and 6g/day for participants \\>51 kg. These doses will be divided into three doses to be taken with meals.",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Ferric Citrate",
                    "description": "Auryxia\u00ae 210 mg ferric iron tablets equivalent to 1 g of FC and matching placebo will be supplied as 200 tablets in 400cc high-density polyethylene bottles.",
                    "armGroupLabels": [
                        "Treatment Arm"
                    ],
                    "otherNames": [
                        "Auryxia"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Placebo to match Ferric Citrate tablets",
                    "armGroupLabels": [
                        "Control Arm"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "iFGF23 levels",
                    "description": "Change in iFGF23 levels",
                    "timeFrame": "6 months and 12 months"
                },
                {
                    "measure": "Safety of Ferric Citrate",
                    "description": "Safety of FC will be compared to Placebo through measures of Adverse Events",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Tolerability of Ferric Citrate",
                    "description": "Tolerability of FC will be compared to Placebo through measures of Adverse Events",
                    "timeFrame": "12 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Effects on Hemoglobin",
                    "description": "Increase in Hemoglobin will be compared between FC and Placebo",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Effects on Transferrin Saturation (TSAT)",
                    "description": "Increase in TSAT will be compared between FC and Placebo",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Effects on Ferritin",
                    "description": "Increase in Ferritin will be compared between FC and Placebo",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Effects on Parathyroid Hormone(PTH)",
                    "description": "Increase in PTH will be compared between FC and Placebo",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Effects on 1,25 D",
                    "description": "Decrease in 1,25 D will be compared between FC and Placebo",
                    "timeFrame": "12 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Ages 6 to 18 years (inclusive);\n2. Estimated Glomerular Filtration Rate (GFR) of 15-59 ml/min per 1.73 m2 by modified Chronic Kidney disease in Children (CKiD) formula;56\n3. Serum phosphate within age appropriate normal levels;\n4. Serum ferritin \\<500 ng/ml and TSAT \\<50%;\n5. For those patients treated with growth hormone, calcitriol, nutritional vitamin D, iron, and/or erythropoiesis-stimulating agents (ESAs) such treatments must have stable dosing for at least 2 weeks prior to screening;\n6. Able to swallow tablets;\n7. Able to eat at least two meals a day;\n8. In the opinion of the investigator, willing and able to follow the study treatment regimen and comply with the site investigator's recommendations.\n\nExclusion Criteria:\n\n1. Patients currently treated with phosphate binders.\n2. History of allergy to all ingredients (including non-medical ingredients) in both products (i.e. investigational product and placebo)\n3. Current intestinal malabsorption, documented in the medical record; significant GI disorders including GI bleeding or active inflammatory bowel disease, inflammatory bowel syndrome, and/or Crohn's Disease\n4. Anticipated initiation of dialysis or kidney transplantation within 6 months\n5. Current or planned future systemic immunosuppressive therapy\n6. Prior solid organ transplantation\n7. Receipt of bone marrow transplant within two years of screening\n8. Current pregnancy, lactation or female subjects who have reached menarche, unless using highly-effective contraception as outlined in section 7.1.1 of Protocol\n9. Patients participating in other interventional study (observational study participation permitted)\n10. Poor adherence to medical treatments in the opinion of the investigator\n11. Hemochromatosis or laboratory tests indicating possible hemochromatosis or other iron overload (primary or secondary) syndrome\n12. Cystinosis\n13. Fanconi syndrome",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "6 Years",
            "maximumAge": "18 Years",
            "stdAges": [
                "CHILD",
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "JENNY BROOK, MS",
                    "role": "CONTACT",
                    "phone": "310-7943144",
                    "email": "jbrook@mednet.ucla.edu"
                },
                {
                    "name": "Barbara Gales, RN",
                    "role": "CONTACT",
                    "email": "bgales@mednet.ucla.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Isidro B Salusky, MD",
                    "affiliation": "University of California, Los Angeles",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of California, Los Angeles",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90095",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Barbara Gales, RN",
                            "role": "CONTACT",
                            "phone": "310-206-0799",
                            "email": "bgales@mednet.ucla.edu"
                        },
                        {
                            "name": "Isidro Salusky, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "University of California, San Francisco",
                    "status": "RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94143",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Daniel Schrader",
                            "role": "CONTACT",
                            "phone": "415-476-9657",
                            "email": "daniel.schrader@ucsf.edu"
                        },
                        {
                            "name": "Farzana Perwad, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Anthony Portale, MD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                },
                {
                    "facility": "Arnold Palmer Hospital for Children",
                    "status": "RECRUITING",
                    "city": "Orlando",
                    "state": "Florida",
                    "zip": "32806",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jill Noland, RN,BSN",
                            "role": "CONTACT",
                            "phone": "321-842-4773",
                            "email": "Jill.noland@orlandohealth.com"
                        },
                        {
                            "name": "Jorge Ramirez, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 28.53834,
                        "lon": -81.37924
                    }
                },
                {
                    "facility": "Emory University",
                    "status": "RECRUITING",
                    "city": "Atlanta",
                    "state": "Georgia",
                    "zip": "30322",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Alexandria Wilkerson, BS",
                            "role": "CONTACT",
                            "phone": "404-727-0851",
                            "email": "Awilke3@emory.edu"
                        },
                        {
                            "name": "Sabina Kennedy, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.749,
                        "lon": -84.38798
                    }
                },
                {
                    "facility": "Children's Mercy Hospital, Kansas City",
                    "status": "RECRUITING",
                    "city": "Kansas City",
                    "state": "Missouri",
                    "zip": "64110",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Stephen Morrison",
                            "role": "CONTACT",
                            "phone": "816-302-3573",
                            "email": "ssmorrison@cmh.edu"
                        },
                        {
                            "name": "Bradley Warady, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.09973,
                        "lon": -94.57857
                    }
                },
                {
                    "facility": "Children's Hospital at Montefiore",
                    "status": "RECRUITING",
                    "city": "Bronx",
                    "state": "New York",
                    "zip": "10467",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Patricia Flynn",
                            "role": "CONTACT",
                            "phone": "718-655-1120",
                            "email": "pflynn@montefiore.org"
                        },
                        {
                            "name": "Frederick Kaskel, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.84985,
                        "lon": -73.86641
                    }
                },
                {
                    "facility": "Cincinnati Children's Hospital Medical Center",
                    "status": "RECRUITING",
                    "city": "Cincinnati",
                    "state": "Ohio",
                    "zip": "45229",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Elizabeth Siry",
                            "role": "CONTACT",
                            "phone": "513-636-7832",
                            "email": "Elizabeth.Siry@cchmc.org"
                        },
                        {
                            "name": "Mark Mitsnefes, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.12713,
                        "lon": -84.51435
                    }
                },
                {
                    "facility": "Children's Hospital of Philadelphia",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Hannah Derwick",
                            "role": "CONTACT",
                            "email": "DERWICKH@chop.edu"
                        },
                        {
                            "name": "Michelle Denburg, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Children's Medical Center, Dallas",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75235",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Melaku Lemma",
                            "role": "CONTACT",
                            "phone": "214-456-8577",
                            "email": "melaku.lemma@childrens.com"
                        },
                        {
                            "name": "Raymond Quigley, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "Baylor College of Medicine",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Franca Ofudu",
                            "role": "CONTACT",
                            "phone": "832-824-7391",
                            "email": "franca.ofudu@bcm.edu"
                        },
                        {
                            "name": "Poyyapakkam R Srivanthos, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "UTH",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ruby Cerda",
                            "role": "CONTACT",
                            "phone": "832-325-7158",
                            "email": "Ruby.D.Cerda@uth.tmc.edu"
                        },
                        {
                            "name": "Joyce Samuel, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "BC Children's Hospital Research Institute",
                    "status": "RECRUITING",
                    "city": "Vancouver",
                    "state": "British Columbia",
                    "zip": "V5Z 4H4",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Linda Li",
                            "role": "CONTACT",
                            "phone": "604-875-2000",
                            "phoneExt": "7558",
                            "email": "Linda.li@bcchr.ca"
                        },
                        {
                            "name": "Tom Blydt-Hansen, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 49.24966,
                        "lon": -123.11934
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "35237863",
                    "type": "DERIVED",
                    "citation": "Hanudel MR, Laster ML, Portale AA, Dokras A, Quigley RP, Guzman GAL, Zaritsky JJ, Hayde NA, Kaskel FJ, Mitsnefes MM, Ramirez JA, Imani PD, Srivaths PR, Kogon AJ, Denburg MR, Blydt-Hansen TD, Reyes LZ, Greenbaum LA, Weidemann DK, Warady BA, Elashoff DA, Mendley SR, Isakova T, Salusky IB. A review of ferric citrate clinical studies, and the rationale and design of the Ferric Citrate and Chronic Kidney Disease in Children (FIT4KiD) trial. Pediatr Nephrol. 2022 Nov;37(11):2547-2557. doi: 10.1007/s00467-022-05492-7. Epub 2022 Mar 2."
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007674",
                    "term": "Kidney Diseases"
                },
                {
                    "id": "D000051436",
                    "term": "Renal Insufficiency, Chronic"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000051437",
                    "term": "Renal Insufficiency"
                },
                {
                    "id": "D000002908",
                    "term": "Chronic Disease"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10698",
                    "name": "Kidney Diseases",
                    "asFound": "Kidney Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26717",
                    "name": "Renal Insufficiency, Chronic",
                    "asFound": "Chronic Kidney Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26718",
                    "name": "Renal Insufficiency",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6147",
                    "name": "Chronic Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M10533",
                    "name": "Iron",
                    "relevance": "LOW"
                },
                {
                    "id": "M21320",
                    "name": "Citric Acid",
                    "relevance": "LOW"
                },
                {
                    "id": "M1837",
                    "name": "Sodium Citrate",
                    "relevance": "LOW"
                },
                {
                    "id": "T382",
                    "name": "Citrate",
                    "asFound": "Type 2",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Micro",
                    "name": "Micronutrients"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AnCoag",
                    "name": "Anticoagulants"
                },
                {
                    "abbrev": "Ot",
                    "name": "Other Dietary Supplements"
                }
            ]
        }
    },
    "hasResults": false
}